CD123-Targeted Nano-Curcumin Molecule Enhances Cytotoxic Efficacy in Leukemic Stem Cells

Acute myeloblastic leukemia (AML) is a disease with a high rate of relapse and drug resistance due to the remaining leukemic stem cells (LSCs). Therefore, LSCs are specific targets for the treatment of leukemia. CD123 is specifically expressed on LSCs and performs as a specific marker. Curcumin is t...

Descripción completa

Detalles Bibliográficos
Autores principales: Nirachonkul, Wariya, Ogonoki, Siriporn, Thumvijit, Tarika, Chiampanichayakul, Supanimit, Panyajai, Pawaret, Anuchapreeda, Songyot, Tima, Singkome, Chiampanichayakul, Sawitree
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620973/
https://www.ncbi.nlm.nih.gov/pubmed/34835741
http://dx.doi.org/10.3390/nano11112974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620973/
https://www.ncbi.nlm.nih.gov/pubmed/34835741
http://dx.doi.org/10.3390/nano11112974

Ejemplares similares